Takeda’s plasma-derived therapies (PDT) business tackles supply-chain challenges to expand access to life-saving treatments, ...
12h
Zacks.com on MSNAre Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now?Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...
Pharmaceutical company Takeda is pioneering a technology-enabled, patient-centered future for plasma-derived therapies ...
CSL has been given approval by the European Commission for Andembry, the first once-monthly preventive therapy for the ...
SoftBank is steering a $500 billion fundraising for the Stargate Project to develop AI infrastructure in the U.S., a plan ...
Takeda Healthcare Philippines, Inc. and Otsuka-Solar Philippines, Inc., with the support of the Embassy of Japan in the Ph ...
Pfizer’s Adcetris combination regimen gets US FDA approval to treat relapsed/refractory diffuse large B-cell lymphoma: New York Friday, February 14, 2025, 11:00 Hrs [IST] Pfizer ...
Sumo wrestling is often seen as a spectacle of brute force—massive men colliding in an explosive test of strength. It’s a ...
DeepSeek may spark a “near-term market correction” for SoftBank and other AI stocks, said chief executive officer Yun Jung-in ...
As Cobra Kai comes to a triumphant finale, we're gathering the best Karate films for your post-Cobra Kai fix. Mr. Miyagi didn ...
Most patients with moderately to severely active Crohn’s disease who achieved endoscopic response and remission after 52 ...
Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results